Worldcrunch
Millions of people could die from antibiotic-resistant germs in the near future. But there are very few new antibiotics in the research pipelines of the big pharmaceutical companies, which are focused on developing more profitable drugs. What is behind this blatant injustice — and what can be done about it?
The country’s food and drug administration should be careful about rubber stamping medical products and procedures just because they’re shiny and new.
U.S. SAYS RUSSIA TARGETING REBELS, NOT ISIS Russia’s intervention in Syria has elicited anger from U.S. officials who are accusing Moscow of aiming at the region’s Western-backed rebels — not ISIS fighters, as the country claims. The New York Times reports that Russia’s participation in the civil war is an effort to help Syrian President […]